Integra LifeSciences suspends new patient enrollment in the clinical trial for DuraGen Plus Adhesion Barrier Matrix in spinal surgery

 Integra announced that it will suspend the enrollment of new patients in the clinical trial for DuraGen Plus® Adhesion Barrier Matrix for evaluating the safety and effectiveness as an adhesion barrier in spinal surgery.

SEC Filing…  http://ow.ly/DcPs